Uvantis Therapeutics, Inc.
Columbia, MD ยท Biotechnology
Uvantis Therapeutics, Inc. is a biotechnology company based in Columbia, Maryland. In a Form D filed with the SEC on September 23, 2026, it reported raising $100,000 from 1 investor as part of an offering of up to $5,000,000. The first sale in the offering took place on September 10, 2026.
- Amount raised
- $100,000
- Offering size
- $5,000,000
- Investors so far
- 1
- First sale
- September 10, 2026
- Securities offered
- Debt, Options or warrants
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Columbia, Maryland
- Incorporated
- Delaware, 2025
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $100,000 | $5,000,000 | 1 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Other health care raises in Maryland
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| ColoWatch, Inc. /MD/ | Gaithersburg, MD | Health Care | $975K | $3M | |
| Templar Nova, Inc. | Rockville, MD | Health Care | $7M | $7M | |
| Monocacy Therapeutics Inc. | Monrovia, MD | Health Care | $25K | $25K | |
| Seraxis Holdings, Inc. | Germantown, MD | Health Care | $10M | $10M | |
| Aromha, Inc. | Potomac, MD | Health Care | $75K | $75K | |
| Functional Longevity Labs, Inc. | Easton, MD | Health Care | $25K | $1M |